Limited Adjuvant Endocrine Therapy for Low Risk Breast Cancer

NCT03917082 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

290

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer Female
Hormone Receptor Positive Tumor

Interventions

DRUG: Tamoxifen Citrate

Sponsor

British Columbia Cancer Agency

Collaborators

[object Object]
[object Object]